Set an alert to watch for an SEC filing on NDTP. When it drops it will be SEC current, and you can buy it, as it will likely uplist to NYSE over night. Right now it has 15-12g non reporting CE-Caveat Emptor block unless you have a Penny stock broker in the US like CSchwab.
Many of us has target estimates of 100 to 300 $$ the first year that filing drops as the float is only 290,000 shares and the OS is only 450,000 with no debt and no new retail shares possible.
Best pick I have found in 40 years.
$NDTP , we know from the shareholder letter, the Nevada SOS updates, 12 years of fees paid to the Nevada SOS and the company naming Hovis the CEO/Director in Late May, and from the OTCmarkets updates who the CEO is, James Hovis, the same person Running CCA, LLC and the attorney doing the SEC package, S-1/1-A, and all of those tell us the Private Biotech CCA, LLC is merging with the old Milv (now known as NDTP ) shell, already renamed NDTP for Nano Delivery Technology Pharmaceuticals Inc.
We know who the founders (2013), founding shareholders of CCA, LLC are, we know they are and have been Building a Billion dollar Biotech, and we know they have been been partnered with the University of Pennsylvania's Medical University Research Hospital's Traumatic Brain Injury teams and they have been successfully testing the soon to be NDTP, BBB-Blood Brain Barrier crossing nano-particle complex (liposome tech) oral IV drink line capable non drug technology that could hit the streets running as drink line, meaning almost immediate revenue.
And Licensing to big Biotechs for use to carry Rx drugs, already approved, for delivery to the brain.....
The float is only 290,000 shares. At $3/share that is $870,000 float,
The news I expect to see will reveal a billion dollar Biotech and billion dollar drink line IMHO.
Going from $870,000 to 1 Billion dollars is a 1000X jump! That means $3/share could see $3000/share.
But we also know the CCA, LLC folks will get shares, and any cash raised (If not already done with CCA, LLC shares ) will add to the OS.
So assume the OS goes from 450,000 to 4,500,000 shhares, a 10X increase.
Then $3000/share becomes a $300/share potential price target
Massive upside potential, and almost zero down side potential.
The stock already traded at $10 to $10.60/share twice.